Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.040 | 0.750 | 4 | 2014 | 2018 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2012 | 2018 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2018 | |||||||
|
0.742 | 0.040 | 2 | 208248468 | synonymous variant | G/A | snv | 5.1E-02 | 6.8E-02 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2018 | ||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2009 | 2018 | ||||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2009 | 2011 | ||||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.720 | 1.000 | 2 | 2011 | 2012 | ||||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Hemic and Lymphatic Diseases | 0.710 | 1.000 | 2 | 2012 | 2016 | ||||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Digestive System Diseases; Neoplasms | 0.710 | 1.000 | 2 | 2016 | 2017 | ||||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.710 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2013 | ||||||||
|
0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2018 | ||||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Nervous System Diseases | 0.020 | 1.000 | 2 | 2018 | 2018 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2017 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
0.020 | 1.000 | 2 | 2015 | 2016 | ||||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2017 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
0.020 | 1.000 | 2 | 2016 | 2018 | ||||||||
|
0.529 | 0.600 | 2 | 208248388 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2018 |